Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Belmonte

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
The Journal of Rheumatology|November 7, 2007
Effectiveness, predictive response factors, and safety of anti-tumor necrosis factor (TNF) therapies in anti-TNF-naive rheumatoid arthritisAntonio Fernández-Nebro, María V Irigoyen, Inmaculada Ureña, et al.
Acta Psychologica|March 16, 2025
Factors influencing the perceived usability of line pay: An extended technology acceptance model approachYogi Tri Prasetyo, Krisna Chandra Susanto, Ko-Hui Chuang, et al.
General and Comparative Endocrinology|October 22, 2011
GnRHa-mediated stimulation of the reproductive endocrine axis in captive Atlantic bluefin tuna, Thunnus thynnusH Rosenfeld, C C Mylonas, C R Bridges, et al.
Genes and Immunity|August 20, 2004
Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSFM Sedegah, Y Charoenvit, J Aguiar, et al.
Molecular Cancer Therapeutics|December 18, 2013
Novel neutralizing hedgehog antibody MEDI-5304 exhibits antitumor activity by inhibiting paracrine hedgehog signalingNeil R Michaud, Youzhen Wang, Kristen A McEachern, et al.
Rheumatology (Oxford, England)|November 30, 2020
Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-upMaría A Martín-Martínez, Santos Castañeda, Fernando Sánchez-Alonso, et al.
ACS Medicinal Chemistry Letters|November 21, 2017
Correction to "Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors"Jeffrey W Johannes, Stephanie Bates, Carl Beigie, et al.
Nature Communications|December 19, 2018
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemiaAdriana E Tron, Matthew A Belmonte, Ammar Adam, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 InhibitorsJeffrey W Johannes, Stephanie Bates, Carl Beigie, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
The Journal of Rheumatology|November 7, 2007
Effectiveness, predictive response factors, and safety of anti-tumor necrosis factor (TNF) therapies in anti-TNF-naive rheumatoid arthritisAntonio Fernández-Nebro, María V Irigoyen, Inmaculada Ureña, et al.
Acta Psychologica|March 16, 2025
Factors influencing the perceived usability of line pay: An extended technology acceptance model approachYogi Tri Prasetyo, Krisna Chandra Susanto, Ko-Hui Chuang, et al.
General and Comparative Endocrinology|October 22, 2011
GnRHa-mediated stimulation of the reproductive endocrine axis in captive Atlantic bluefin tuna, Thunnus thynnusH Rosenfeld, C C Mylonas, C R Bridges, et al.
Genes and Immunity|August 20, 2004
Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSFM Sedegah, Y Charoenvit, J Aguiar, et al.
Molecular Cancer Therapeutics|December 18, 2013
Novel neutralizing hedgehog antibody MEDI-5304 exhibits antitumor activity by inhibiting paracrine hedgehog signalingNeil R Michaud, Youzhen Wang, Kristen A McEachern, et al.
Rheumatology (Oxford, England)|November 30, 2020
Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-upMaría A Martín-Martínez, Santos Castañeda, Fernando Sánchez-Alonso, et al.
ACS Medicinal Chemistry Letters|November 21, 2017
Correction to "Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors"Jeffrey W Johannes, Stephanie Bates, Carl Beigie, et al.
Nature Communications|December 19, 2018
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemiaAdriana E Tron, Matthew A Belmonte, Ammar Adam, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 InhibitorsJeffrey W Johannes, Stephanie Bates, Carl Beigie, et al.
Pageof 15